Beyond the Hype: Strategies for scaling high-value, GxP compliant agentic AI for Life Sciences
Discover how leading pharmaceutical and biotech organizations are scaling high-value, GxP-compliant agentic AI in production.
Category
On-demand Webinar
Duration
66:15
Watch this video
78% of life sciences executives believe they have AI agents running in production. Only 26% actually do. Watch this on-demand session to learn what the leading pharmaceutical and biotech organizations are doing differently, and how they scale agentic AI without compromising GxP compliance.
The Real State of Agentic AI in Life Sciences, and What It Takes to Scale It Under GxP
Agentic AI could reshape how life sciences organizations discover, develop, manufacture, and monitor therapies. Most are still stuck in pilots. New research found that while 78% of life sciences executives believe they have agents running in production, only 26% actually do. The barrier is rarely the model. It is trust: accurate answers, connected data, and the traceability regulators expect.
This on-demand session draws on The State of Enterprise Agentic AI in 2026, a study of 740 AI and business leaders across enterprises generating more than 5 billion dollars in revenue across North America and Europe. It delivers an unfiltered look at where life sciences stands today, and what separates the leaders from everyone else.
Watch Dhaval Patel, Global Industry Leader, Life Sciences at ChapsVision, as he unpacks the research findings, and Eric Staib, Vice President of Corporate Quality at Syneos Health, as he shares how quality and compliance leaders balance innovation with the governance required to put AI to work in regulated environments. Together, they explore how successful adopters move from experimentation to validated, auditable AI across drug discovery, clinical development, manufacturing, and pharmacovigilance.
What You’ll Learn
The real state of agentic AI in life sciences
Why there is such a large gap between perceived and actual adoption, and how life sciences compares against cross-industry benchmarks.
Why most organizations stall after the pilot
The biggest barriers keeping pharma and biotech teams from scaling, and what the leading 26% do differently to break through.
Building a context layer your AI can trust
How leaders prioritize accuracy, break down data silos, and build a knowledge layer so their AI knows what the enterprise knows.
Traceability and auditability as a GxP foundation
Why every agent action must be explainable and auditable, and how leaders build this in from day one instead of retrofitting it for inspection.
Governance and quality in regulated environments
A quality leader’s view on scaling agentic AI under GxP, and how strong governance turns compliance into a path to high-value use cases.
From high-value use cases to Operational AI
How to prove agentic AI on the use cases that matter most, plus the core components of an Operational AI platform built for regulated environments.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
